SINOVAC BIOTECH LTD Increase (Decrease) in Deferred Revenue
SINOVAC BIOTECH LTD (SVA) reported Increase (Decrease) in Deferred Revenue of -$1.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-06-05
| Period end | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$1.46M 20-F · filed 2026-06-05 | |
| 2024-12-31 | -$14.44M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $2.23M 20-F · filed 2026-06-05 | $2.88M 20-F · filed 2024-04-29 |
| 2022-12-31 | -$50.50M 20-F · filed 2026-04-30 | -$58.48M 20-F · filed 2023-05-01 |
| 2021-12-31 | -$288.78M 20-F · filed 2026-04-30 | |
| 2020-12-31 | $339.33M 20-F · filed 2023-05-01 | |
| 2019-12-31 | $2.52M 20-F · filed 2022-04-29 | |
| 2018-12-31 | -$892.00K 20-F · filed 2021-04-22 |